| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |